.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

GABAPENTIN Drug Profile

« Back to Dashboard
Gabapentin is a drug marketed by Sciegen Pharms Inc, Alkem Labs Ltd, Acella Pharms Llc, Invagen Pharms, Ranbaxy, Sun Pharm Inds Ltd, Marksans Pharma, Ivax Sub Teva Pharms, Sandoz, Amneal Pharms, Zydus Pharms Usa Inc, Teva, Amneal Pharms Ny, Teva Pharms, Mylan Pharms Inc, Sun Pharm Inds, Aci Healthcare Ltd, Actavis Elizabeth, Hikma, Aurobindo Pharma Ltd, Alkem, Mylan, Apotex Inc, Taro, Glenmark Generics, Hi Tech Pharma, Hikma Pharms, Watson Labs, Tris Pharma Inc, and Aurobindo Pharm. and is included in forty-two NDAs. It is available from ninety-six suppliers.

The generic ingredient in GABAPENTIN is gabapentin. There are twenty-six drug master file entries for this compound. Ninety-nine suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the gabapentin profile page.

Summary for Tradename: GABAPENTIN

Patents:0
Applicants:30
NDAs:42
Suppliers / Packagers: see list96
Drug Prices: :see details

Pharmacology for Tradename: GABAPENTIN

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro
GABAPENTIN
gabapentin
CAPSULE;ORAL077261-003Aug 2, 2013RXNo► subscribe► subscribe
Apotex Inc
GABAPENTIN
gabapentin
TABLET;ORAL077894-002Oct 10, 2006RXNo► subscribe► subscribe
Mylan Pharms Inc
GABAPENTIN
gabapentin
TABLET;ORAL090335-002Jun 1, 2010RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc